Among the free-form ARSs, tryptophanyl-tRNA synthetase (WRS) and tyrosyl-tRNA synthetase (YRS) can be secreted and modified to control angiogenesis and immune responses in the tumor microenvironment. The gene discussed is YARS1; the disease is neoplasm.